Health
Judd Moul, MD, Reviews Studies From 2021 ASCO Showing Systemic Therapy Advancements in Prostate Cancer – Cancer Network
Judd Moul, MD, discusses the gravity of new data on systemic therapies for men with castration-resistant prostate cancer and…
Both trials demonstrated benefit of the experimental therapy in their respective patient cohorts, helping prolong overall survival versus standard-of-care regimens.
In an interview with CancerNetwork®, Judd Moul, MD, discussed these findings from the meeting…
Continue Reading